The system is intended for use in urgent care clinics, primary care settings, physician office laboratories, and pharmacies.

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

Assuming you can get your hands on a COVID-19 home test kit — they’ve been in high demand, thanks to the omicron variant — you probably have questions. Am I testing too early or late? Is this brand or ...

In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel or established treatments, and monitor health.

The Canada Point of Care Molecular Diagnostics Market, valued at USD 350 million in 2024, is projected to reach USD 560 ...

Last spring, a rapid polymerase chain reaction (PCR) test for COVID-19 — developed by Northwestern University spinoff company Minute Molecular Diagnostics — received emergency use authorization (EUA) ...

Lateral flow tests (LFTs) are quick and easy to take at home, giving a result within 20-30 minutes. They look for proteins on the surface of the virus, which are easily detected. However, they have a ...

After the start of the SARS-C0V-2 pandemic, investigators from ResearchPath LLC and their collaborators at Rutgers University quickly dedicated resources to develop accurate and reliable COVID-19 ...

Global Molecular Infectious Disease Testing Market OverviewThe global molecular infectious disease testing market is ...

As SARS-C0V-2 variants emerged, researchers developed a PCR test that uses molecular beacons not only to diagnose COVID-19 infection, but also to identify the specific variant causing that infection.

CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or ...